The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study

NCT05462548 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia Major
Transfusion-dependent Anemia

Interventions

DRUG: Luspatercept Injectable Product

Sponsor

Sun Yat-sen University